Selegiline
Synonym(s):(-)-Deprenyl
- CAS NO.:14611-51-9
- Empirical Formula: C13H17N
- Molecular Weight: 187.28
- MDL number: MFCD00672171
- EINECS: 604-507-3
- SAFETY DATA SHEET (SDS)
- Update Date: 2023-05-04 15:34:20
What is Selegiline?
Absorption
Rapidly absorbed from the gastrointestinal tract.
Toxicity
LD50=63 mg/kg (rats, IV)
Description
Selegiline, a monoamine oxidase (MAO) inhibitor, is FDA-approved as an adjunct treatment in the management of patients with Parkinson disease and as a treatment for a major depressive disorder (MDD) in adults. Selegiline is also used off-label for early Parkinson disease and the treatment of attention-deficit/hyperactivity disorder (ADHD).
The Uses of Selegiline
This drug is a selective inhibitor of monoaminooxidase B, which suppresses dopamineinactivation processes and facilitates an increase of its level in the brain. In treating Parkinsonism, selegiline is usually used in combination with levodopa.
The Uses of Selegiline
Antidyskinetic; antiparkinsonian (in combination with levodopa/carbidopa).
Background
A selective, irreversible inhibitor of Type B monoamine oxidase. It is used in newly diagnosed patients with Parkinson's disease. It may slow progression of the clinical disease and delay the requirement for levodopa therapy. It also may be given with levodopa upon onset of disability. (From AMA Drug Evaluations Annual, 1994, p385) The compound without isomeric designation is Deprenyl.
Indications
Monotherapy for initial treatment of Parkinson's disease, as well as an adjunct therapy in patients with a decreased response to levodopa/carbadopa. Also used for the palliative treatment of mild to moderate Alzheimer's disease and at higher doses, for the treatment of depression.
Definition
ChEBI:(-)-selegiline is a selegiline and a terminal acetylenic compound. It has a role as a geroprotector. It is a conjugate base of a (-)-selegiline(1+).
brand name
Emsam (Somerset).
World Health Organization (WHO)
Selegiline was introduced in the early 1990s. It is a monoamine oxidase inhibitor and is used in the management of Parkinson's disease. A symptomatic effect of selegiline in Parkinson's disease has been shown, but longer follow-up failed to provide any definitive evidence of ability to retard the loss of dopaminergic neurons (Parkinson's Study Group, 1993).
Biological Functions
Another drug used in the treatment of Parkinson’s disease
is selegiline (also known as deprenyl, or Eldepryl).
It is an irreversible inhibitor of MAO-B, an important
enzyme in the metabolism of dopamine (Fig. 33.2).
Blockade of dopamine metabolism makes more
dopamine available for stimulation of its receptors.
Selegiline, as monotherapy, may be effective in the
newly diagnosed patient with parkinsonism because its
pharmacological effect enhances the actions of endogenous
dopamine.
Selegiline is also used in conjunction with levodopa–
carbidopa in later-stage parkinsonism to reduce levodopa
dosage requirements and to minimize or delay
the onset of dyskinesias and motor fluctuations that
usually accompany long-term treatment with levodopa.
It has also been proposed that selegiline may slow the
progression of the disease by reducing the formation of
toxic free radicals produced during the metabolism of
dopamine. However, any neuroprotective effect
of selegiline in parkinsonian patients remains to be
established.
Most of the adverse reactions to selegiline are related
to actions of increased levels of dopamine, as discussed
earlier. At recommended doses, and unlike the
nonselective MAO inhibitors used in the treatment of
depression, selegiline has little effect on MAO-A and
therefore generally does not cause the hypertension associated
with the ingestion of tyramine-enriched foods. However, at doses higher than those
usually recommended, MAO-A may be inhibited,
which increases the risk of a tyramine reaction.
Selegiline should not be coadministered with tricyclic
antidepressants or selective serotonin uptake inhibitors
because of the possibility of a severe adverse drug reaction
(e.g., hyperpyrexia, agitation, delirium, coma).
Pharmacokinetics
Dopamine is an essential chemical that occurs in many parts of the body. It is the premature degradation of dopamine that results in the symptoms of Parkinson's disease. Monoamine oxidase (MAO) is an enzyme which accelerates the breakdown of dopamine. Selegiline can prolong the effects of dopamine in the brain by preventing its breakdown through seletively blocking MAO-B. It also may prevent the removal of dopamine between nerve endings and enhance release of dopamine from nerve cells.
Synthesis
Selegiline, N-methyl-N-(2-propinyl)-2-methyl-1-phenylethylamine (10.1.14), is synthesized by the alkylation of (-)methyamphetamine (8.1.2.3) using propargylbromide [20¨C23].
Metabolism
Properties of Selegiline
Melting point: | 137.5-139 °C |
Boiling point: | 273℃ |
alpha | D20 -11.2° |
Density | 0.954 |
refractive index | nD20 1.5180 |
Flash point: | 108℃ |
storage temp. | -20°C |
pka | 7.53±0.50(Predicted) |
CAS DataBase Reference | 14611-51-9 |
Safety information for Selegiline
Signal word | Danger |
Pictogram(s) |
Flame Flammables GHS02 Skull and Crossbones Acute Toxicity GHS06 Health Hazard GHS08 |
GHS Hazard Statements |
H225:Flammable liquids H370:Specific target organ toxicity, single exposure |
Precautionary Statement Codes |
P210:Keep away from heat/sparks/open flames/hot surfaces. — No smoking. P260:Do not breathe dust/fume/gas/mist/vapours/spray. P280:Wear protective gloves/protective clothing/eye protection/face protection. P311:Call a POISON CENTER or doctor/physician. P301+P310:IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
Computed Descriptors for Selegiline
Abamectin manufacturer
New Products
ALUMINIUM IODIDE 100 GM BUFFER CAPSULE PH 7.0 - 10 CAP BUFFER SOLUTION PH 9.5 (BORATE) EZEE BLUE GEL STAINER BORAX CARMINE (GRENACHERS ALCOHOLIC) POTASSIUM IODATE - IODIDE SOLN 0.1 N Dabigatran Acyl-O3-D-Glucuronide Trifluoroacetic Acid Salt Isofolic Acid Dabigatran 2-O-acylglucuronide metabolite Dabigatran Acyl-?-D- glucuronide Trifluroacetic Acid Erythromycin EP Impurity A Desloratidine Related Compound ARelated products of tetrahydrofuran
You may like
-
Selegiline 99%View Details
-
14611-51-9 98%View Details
14611-51-9 -
Dechloro DesloratadineView Details
-
Dehydro DesloratadineView Details
-
Edoxaban Impurity 57View Details
2089454-69-1 -
Empagliflozin Bromo ImpurityView Details
-
Glycopyrronium Bromide EP Impurity IView Details
1404617-94-2 -
Ipratropium EP Impurity BView Details
58073-59-9